ROLE OF DOPAMINE D1- AND D2-RECEPTORS IN THE DELTA1-OPIOIDERGIC IMMUNOSTIMULATION

Cover Page


Cite item

Full Text

Abstract

The study has shown that activation of delta1-opioid receptors by a highly selective peptide agonist DPDPE (100 µg/kg) results in a significant increase of the immune response to antigen (SRBC, 5×108) in CBA mice. SCH-23390 (1 mg/kg), a selective antagonist of the postsynaptic dopamine D1-receptors, and selective D2-blocker haloperidol (1 mg/kg) prevented immunostimulating effect of DPDPE. Comparison of effects of the antagonists suggests that delta1-opioidergic immunostimulation has more significant impact due to involvement of dopamine D1-receptors.

 

About the authors

M. A. Cheido

Federal State Budgetary Institution «Research Institute of Physiology» under the Siberian Branch of the Russian Academy
of Medical Sciences , Novosibirsk

Author for correspondence.
Email: cheido@physiol.ru
кандидат биологических наук, ведущий научный сотрудник лаборатории меха- низмов нейрохимической модуляции ФГБУ «Научно-исследовательский институт физиологии» Сибирского отде- ления РАМН Адрес: 630117, Новосибирск, ул. Академика Тимакова, д. 4 Тел.: (383) 335-98-58 Факс: (383) 335-98-54 Россия

M. M. Gevorkyan

Federal State Budgetary Institution «Research Institute of Physiology» under the Siberian Branch of the Russian Academy
of Medical Sciences , Novosibirsk

Email: gevorgyanmm@ngs.ru
кандидат биологических наук, ведущий научный сотрудник лаборатории меха- низмов нейрохимической модуляции ФГБУ «Научно-исследовательский институт физиологии» Сибирского отде- ления РАМН Адрес: 630117, Новосибирск, ул. Академика Тимакова, д. 4 Тел.: (383) 335-98-58 Факс: (383)335-98-54 Россия

References

  1. Coop A., Rice K.C. Role of w-opioid receptors in biological processes. Drug News Perspect. 2000; 13 (13): 481–487.
  2. Varona A., Gill J., Saracibar G. et al. Effects of imipramine treatment on delta-opioid receptors of the rat brain cortex and striatum. Arzneimittelforschung. 2003; 53 (1): 21–25.
  3. Chei`do M.A., Idova G.V. Rol` serotoninovy`kh retceptorov v del`taopioidnoi` immunosupressii. Ros. fiziol. zhurn. im. I.M.Sechenova. 2010; 96 (2): 1234–1240.
  4. Husted T.L., Govindaswami M., Oeltgen P.R. et al. A delta2-opioid agonist inhibits p38 MARK and suppresses activation of murine macrophages. J Surg Res. 2005; 128 (1): 45–49.
  5. Rahim R.T., Meissier J.J., Cowan A. et al. Administration of mu-, kappa- or delta2-receptor agonists via osmotic minipumps suppresses murine splenic antibody responses. Int. Immunopharmacol. 2001; 1 (11): 2001–2009.
  6. Smakhtin M.Y., Konoplya A.I., Sever’yanova L.A., Shveinov I.A. DSLET and ACTH(4-10) increase mitotic activity of hepatocytes and suppress antibody production. Bull Exp. Biol. Med. 2003; 135 (5): 428–429.
  7. Kim K.W., Kim S.J., Shin B.S., Choi H.J. Ligand binding profiles of delta-opioid receptor in human cerebral cortex membranes: evidence of delta-opioid receptor heterogeneity. Life Sci. 2001; 68 (14): 1649–1656.
  8. Cheido M.A., Idova G.V., Devoino L.V. Involvement of deltaopioid receptors in immunosuppression. Inter. J. Neurosci. 1996; 84: 195–203.
  9. Devoino L., Cheido M., Alperina E., Idova G. Evidence for a role of dopaminergic mechanisms in the immunostimulating effect of µ-opioid receptor agonist DAGO. Intern. J. Neurosci. 2003; 113: 1381–1394.
  10. Cunningham A.J. A method of increased sensitivity for detecting single antibody forming cells. Nature. 1965; 207: 1106– 1107.
  11. Hiller J.M., Fan LQ., Simon E.J. Autoradiographic comparison of [3]DPDPE and [3]DSLET binding: evidence for distinct delta 1 and delta 2 opioid receptor populations in rat brain. Brain Res. 1996; 719 (1–2): 85–95.
  12. Nistico G., Caroleo M.C., Arbitrio M., Pulvirenti L. Evidence for involvement of dopamine D1 receptors in the limbic system in the control of immune mechanisms. Neuroimmunomodulation. 1994; 1 (3): 174–180.
  13. Devoi`no L.V., Al`perina E.L., Gevorgian M.M., Chei`do M.A. Uchastie v immunostimuliatcii dofaminovy`kh D1- i D2-retceptorov prilezhashchego iadra u qry`s. Ros. fiziol. zhurn. im. I.M.Sechenova. 2005; 91 (11): 1281–1287.
  14. Hirose N., Murakawa K., Takada K. et al. Interactions aming mu- and delta-opioid receptors, especially putative delta1- and delta2- opioid receptors, promote dopamine release in the nucleus accumbens. Neuroscience. 2005; 135 (1): 213–225.
  15. Chei`do M.A., Idova G.V. Differentcirovanny`i` vclad dofaminovy`kh D1- i D2-retceptorov v µ-opioidergichesquiu immunomoduliatciiu. Ros. fiziol. zhurn. im. I.M.Sechenova. 2006; 92 (5): 546–551.
  16. Ambrose L.M., Gallagher S.M., Unterwald E.M., Van Bockstaele E.J. Dopamine D1 and delta-opioid receptors co-exist in rat striatal neurons. Neurosci. Lett. 2006; 399 (3): 191–196.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2012 "Paediatrician" Publishers LLC



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies